Leading compounds for the validation of animal models of psychopathology (Q38128733)

29 August 2017

Leading compounds for the validation of animal models of psychopathology (English)

1 reference

29 August 2017

Vincenzo Micale

1

1 reference

29 August 2017

Jana Kucerova

series ordinal

2

1 reference

29 August 2017

Alexandra Sulcova

series ordinal

3

1 reference

29 August 2017

15 August 2013

1 reference

29 August 2017

Cell and Tissue Research

1 reference

29 August 2017

354

1 reference

29 August 2017

309-330

1 reference

29 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s00441-013-1692-9

29 August 2017

0 references

cites work

Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The neurobiology of depression--revisiting the serotonin hypothesis. II. Genetic, epigenetic and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Endocannabinoid system dysfunction in mood and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Modeling cholinergic aspects of schizophrenia: focus on the antimuscarinic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Dissociating scopolamine-induced disrupted and persistent latent inhibition: stage-dependent effects of glycine and physostigmine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The M₁/M₄ preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Disruption of prefrontal cortical-hippocampal balance in a developmental model of schizophrenia: reversal by sulpiride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Active behaviours produced by antidepressants and opioids in the mouse tail suspension test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Dopaminergic and opioidergic mediations of tricyclic antidepressants in the learned helplessness paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Animal models of social stress: effects on behavior and brain neurochemical systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Effects of Subchronic Phencyclidine (PCP) Treatment on Social Behaviors, and Operant Discrimination and Reversal Learning in C57BL/6J Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Clozapine administration reverses behavioral, neuronal, and nitric oxide disturbances in the neonatal ventral hippocampus rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Preclinical evaluation of non-imidazole histamine H3 receptor antagonists in comparison to atypical antipsychotics for the treatment of cognitive deficits associated with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Schizophrenia-like GABAergic gene expression deficits in cerebellar Golgi cells from rats chronically exposed to low-dose phencyclidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Activation of 5-HT(6) receptors facilitates attentional set shifting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Effect of amitriptyline on avoidance learning in rats following olfactory bulb ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Sex differences in response to oral amitriptyline in three animal models of depression in C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Characterization of an mGluR2/3 negative allosteric modulator in rodent models of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Dysregulation of kisspeptin and neurogenesis at adolescence link inborn immune deficits to the late onset of abnormal sensorimotor gating in congenital psychological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Reduced reelin protein synthesis in ventral hippocampus of isolation reared Wistar rats accompanies impaired avoidance conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

mGlu2/3 and mGlu5 receptors: potential targets for novel antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Hyperforin as a possible antidepressant component of hypericum extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Stereospecific reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Learned helplessness: validity and reliability of depressive-like states in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Synergistic antidepressant-like action of gaboxadol and escitalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Emerging drugs for major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Assessing antidepressant activity in rodents: recent developments and future needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Reactivity of 5-HT1A receptor in adult rats after neonatal noradrenergic neurons' lesion--implications for antidepressant-like action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Rolipram attenuates MK-801-induced deficits in latent inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Effects of risperidone, clozapine and the 5-HT6 antagonist GSK-742457 on PCP-induced deficits in reversal learning in the two-lever operant task in male Sprague Dawley rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Tianeptine treatment induces antidepressive-like effects and alters BDNF and energy metabolism in the brain of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Alpha-methyl-para-tyrosine antagonizes the effect of chronic imipramine on learned helplessness in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Sustained impairment of α2A-adrenergic autoreceptor signaling mediates neurochemical and behavioral sensitization to amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Increasing the validity of experimental models for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Disruptions in spatial working memory, but not short-term memory, induced by repeated ketamine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Pharmacological characterization of social isolation-induced hyperactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The amphetamine-induced sensitized state as a model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Acute N-methyl-D-aspartate receptor hypofunction induced by MK801 evokes sex-specific changes in behaviors observed in open-field testing in adult male and proestrus female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a lin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Selective H3 receptor (H3R) blockade: broad efficacy in cognition and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Fluoxetine modulates hippocampal cell signaling pathways implicated in neuroplasticity in olfactory bulbectomized mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Social memory in mice: disruption with an NMDA antagonist and attenuation with antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Selective remediation of reversal learning deficits in the neurodevelopmental MAM model of schizophrenia by a novel mGlu5 positive allosteric modulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The mGlu₅ positive allosteric modulator LSN2463359 differentially modulates motor, instrumental and cognitive effects of NMDA receptor antagonists in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The effect of imipramine and lithium on "learned helplessness" and acetylcholinesterase in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Animal behavior models of the mechanisms underlying antipsychotic atypicality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Post-weaning social isolation rearing influences the expression of molecules related to inhibitory neurotransmission and structural plasticity in the amygdala of adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

In vitro characterisation of the novel positive allosteric modulators of the mGlu₅ receptor, LSN2463359 and LSN2814617, and their effects on sleep architecture and operant responding in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Nitric oxide modulates apomorphine-induced recognition memory deficits in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

NNZ-2591, a novel diketopiperazine, prevented scopolamine-induced acute memory impairment in the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Selective potentiation of the metabotropic glutamate receptor subtype 2 blocks phencyclidine-induced hyperlocomotion and brain activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Neonatal disruption of serine racemase causes schizophrenia-like behavioral abnormalities in adulthood: clinical rescue by d-serine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Stimulation of the metabotropic glutamate 2/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Deficits in parvalbumin and calbindin immunoreactive cells in the hippocampus of isolation reared rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

A stereological comparison of GAD67 and reelin expression in the hippocampal stratum oriens of offspring from two mouse models of maternal inflammation during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Chronic administration of citalopram in olfactory bulbectomy rats restores brain 5-HT synthesis rates: an autoradiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The role of glutamate on the action of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Stress models of depression: forming genetically vulnerable strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Post-weaning chronic social isolation produces profound behavioral dysregulation with decreases in prefrontal cortex synaptic-associated protein expression in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Aging impairs the antidepressant-like response to citalopram in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Stimulation of metabotropic glutamate (mGlu) 2 receptor and blockade of mGlu1 receptor improve social memory impairment elicited by MK-801 in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Mice with genetically altered glutamate receptors as models of schizophrenia: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Subchronic treatment with imipramine ameliorates the decreased number in neuropeptide Y-positive cells in the hippocampus of learned helplessness rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Altered RNA editing of serotonin 2C receptor in a rat model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Hippocampal synapsin I, growth-associated protein-43, and microtubule-associated protein-2 immunoreactivity in learned helplessness rats and antidepressant-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

A dysphoric-like state during early withdrawal from extended access to methamphetamine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Twenty-five years of glutamate in schizophrenia: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Animal models of depression: parallels and correlates to severe depression in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable mild stress-induced depression-like behavior and brain oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Activation of post-synaptic 5-HT(1A) receptors in the dorsal hippocampus prevents learned helplessness development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Post-stress facilitation of serotonergic, but not noradrenergic, neurotransmission in the dorsal hippocampus prevents learned helplessness development in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulata

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Animal models of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Differential behavioural and neurochemical outcomes from chronic paroxetine treatment in adolescent and adult rats: a model of adverse antidepressant effects in human adolescents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Increased binding of cortical and hippocampal group II metabotropic glutamate receptors in isolation-reared mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Phosphodiesterase 10A inhibitors: a 2009 - 2012 patent update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The effect of tianeptine and sertraline in three animal models of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Effects of chronic desipramine on waiting behaviour for a food reward in olfactory bulbectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The olfactory bulbectomized rat as a model of depression: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Repeated potentiation of the metabotropic glutamate receptor 5 and the alpha 7 nicotinic acetylcholine receptor modulates behavioural and GABAergic deficits induced by early postnatal phencyclidine (PCP) treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Translating potential biomarker candidates for schizophrenia and depression to animal models of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Effects of ketamine and LY341495 on the depressive-like behavior of repeated corticosterone-injected rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The effects of methamphetamine self-administration on behavioural sensitization in the olfactory bulbectomy rat model of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Biological rhythms and melatonin in mood disorders and their treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Early cognitive experience prevents adult deficits in a neurodevelopmental schizophrenia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Effect of the 5-HT6 receptor antagonists Ro04-6790 and Ro65-7199 on latent inhibition and prepulse inhibition in the rat: comparison to clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Time course of the attenuation effect of repeated antipsychotic treatment on prepulse inhibition disruption induced by repeated phencyclidine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Importance of inter-hemispheric prefrontal connection in the effects of non-competitive NMDA receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Prefrontal dopamine release and sensory-specific satiety altered in rats with neonatal ventral hippocampal lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Fluoxetine reverses depressive-like behaviors and increases hippocampal acetylcholinesterase activity induced by olfactory bulbectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Novel glutamatergic agents for major depressive disorder and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Antipsychotic effects of N-desmethylclozapine on sensorimotor gating function in rats--possible involvement of activation of M(1) muscarinic receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Protective effects of histamine H3-receptor ligands in schizophrenic behaviors in experimental models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

An animal model of schizophrenia based on chronic LSD administration: old idea, new results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Influence of social isolation in the rat on serotonergic function and memory--relevance to models of schizophrenia and the role of 5-HT₆ receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Attenuation of chronic mild stress-induced 'anhedonia' by asenapine is not associated with a 'hedonic' profile in intracranial self-stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Is there a relationship between 5-HT1B receptors and the mechanisms of action of antidepressant drugs in the learned helplessness paradigm in rats?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The effect of monoamine oxidase inhibitors compared with classical tricyclic antidepressants on learned helplessness paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Antidepressant efficacy of olanzapine as monotherapy in major depressive disorder, without psychosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Neuropathological and Reelin deficiencies in the hippocampal formation of rats exposed to MAM; differences and similarities with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on the latent inhibition of the conditioned emotional response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Melatonin affects the immobility time of rats in the forced swim test: the role of serotonin neurotransmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Endocannabinoid system and mood disorders: priming a target for new therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Learned helplessness, depression and the perception of reinforcement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Antidepressant treatment and rodent aggressive behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

5-HT6 receptors: a novel target for cognitive enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

BGC20-761, a novel tryptamine analog, enhances memory consolidation and reverses scopolamine-induced memory deficit in social and visuospatial memory tasks through a 5-HT6 receptor-mediated mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The effects of PRX-07034, a novel 5-HT6 antagonist, on cognitive flexibility and working memory in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Cortisol responses to psychosocial stress predict depression trajectories: social-evaluative threat and prior depressive episodes as moderators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Differential laminar effects of amphetamine on prefrontal parvalbumin interneurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Mouse strain differences in phencyclidine-induced behavioural changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Antidepressant-like properties of three new α2-adrenoceptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Schizophrenia: from developmental deviance to dopamine dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Effects of fluoxetine, tianeptine and olanzapine on unpredictable chronic mild stress-induced depression-like behavior in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Behavioural alterations relevant to developmental brain disorders in mice with neonatally induced ventral hippocampal lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptor and cytochrome P450 2D6 in Japanese patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Cholinergic and glutamatergic activation reverses working memory failure by hippocampal histamine H1 receptor blockade in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Preclinical models: status of basic research in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Animal models of depression and anxiety: What do they tell us about human condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Acute effects of combining citalopram and pindolol on regional brain serotonin synthesis in sham operated and olfactory bulbectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The 5-hydroxytryptamine (serotonin) receptor 6 agonist EMD 386088 ameliorates ketamine-induced deficits in attentional set shifting and novel object recognition, but not in the prepulse inhibition in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Cortical disinhibition in the neonatal ventral hippocampal lesion model of schizophrenia: new vistas on possible therapeutic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Differential effects of antipsychotics on hippocampal presynaptic protein expressions and recognition memory in a schizophrenia model in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

An analysis of the effects of acute and chronic fluoxetine on extracellular norepinephrine in the rat hippocampus during stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Sex differences in the effects of N,N-diethyllysergamide (LSD) on behavioural activity and prepulse inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Behavioral animal models of antipsychotic drug actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Forced swimming test in mice: a review of antidepressant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Felbamate reduces hormone release and locomotor hypoactivity induced by repeated stress of social defeat in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Tiagabine treatment is associated with neurochemical, immune and behavioural alterations in the olfactory bulbectomized rat model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Effects of sub-anesthetic doses of ketamine on rats' spatial and non-spatial recognition memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Synaptic transmission changes in fear memory circuits underlie key features of an animal model of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Agomelatine: innovative pharmacological approach in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Animal models of depression: utility for transgenic research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Depression: a new animal model sensitive to antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Deep brain stimulation of the entopeduncular nucleus in rats prevents apomorphine-induced deficient sensorimotor gating.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The delta opioid receptor: an evolving target for the treatment of brain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

CEP-26401 (irdabisant), a potent and selective histamine H₃ receptor antagonist/inverse agonist with cognition-enhancing and wake-promoting activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Maintenance treatment with fluoxetine is necessary to sustain normal levels of synaptic markers in an experimental model of depression: correlation with behavioral response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Drug withdrawal-induced depression: serotonergic and plasticity changes in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The ubiquitin-proteasome system regulates the stability of neuronal nicotinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Chronic fluoxetine treatment attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Behavioural consequences of withdrawal from three different administration schedules of amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Anhedonia and motivational deficits in rats: impact of chronic social stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Effects of fluoxetine on behavioral deficits evoked by chronic social stress in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Effects of milnacipran and fluvoxamine on hyperemotional behaviors and the loss of tryptophan hydroxylase-positive cells in olfactory bulbectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

(+) MK-801 and phencyclidine induced neurotoxicity do not cause enduring behaviours resembling the positive and negative symptoms of schizophrenia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Chronic buspirone treatment decreases 5-HT1B receptor densities and the serotonin transporter but increases the density of 5-HT2A receptors in the bulbectomized rat model of depression: an autoradiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Comparison of the mGlu(5) receptor positive allosteric modulator ADX47273 and the mGlu(2/3) receptor agonist LY354740 in tests for antipsychotic-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Effects of a positive allosteric modulator of mGluR5 ADX47273 on conditioned avoidance response and PCP-induced hyperlocomotion in the rat as models for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Pramipexole is active in depression tests and modulates monoaminergic transmission, but not brain levels of BDNF in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Agonistic behavior of mice and rats: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Pharmacological properties of glutamatergic drugs targeting NMDA receptors and their application in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Adolescent chronic apomorphine treatment impairs latent inhibition and reduces prefrontal cortex mGluR5 receptor expression in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Specificity of the learned helplessness model of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

D-Serine and a glycine transporter-1 inhibitor enhance social memory in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Metabolic mapping of the effects of the antidepressant fluoxetine on the brains of congenitally helpless rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The effects of isolated and enriched housing conditions on baseline and drug-induced behavioural responses in the male rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Reversal of scopolamine-induced disruption of prepulse inhibition by clozapine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Improvement of phencyclidine-induced social behaviour deficits in rats: involvement of 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Gestational methylazoxymethanol exposure leads to NMDAR dysfunction in hippocampus during early development and lasting deficits in learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The olfactory bulbectomised rat as a model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Psychotic symptoms in methamphetamine psychotic in-patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Effect of olfactory bulbectomy and chronic amitryptiline treatment in rats. 3H-imipramine binding and behavioral analysis by swimming and open field tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Sensory and sensorimotor gating deficits after neonatal ventral hippocampal lesions in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Availability of learned helplessness test as a model of depression compared to a forced swimming test in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Antipsychotic action of selective group II metabotropic glutamate receptor agonist MGS0008 and MGS0028 on conditioned avoidance responses in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Behavioural and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Modulation of prepulse inhibition through both M(1) and M (4) muscarinic receptors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Roles of glutamate signaling in preclinical and/or mechanistic models of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

T-817MA, a novel neurotrophic agent, ameliorates loss of GABAergic parvalbumin-positive neurons and sensorimotor gating deficits in rats transiently exposed to MK-801 in the neonatal period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Mutant mouse models of depression: candidate genes and current mouse lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Antipsychotic drugs rapidly induce dopamine neuron depolarization block in a developmental rat model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The difference in effect of mGlu2/3 and mGlu5 receptor agonists on cognitive impairment induced by MK-801.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Antipsychotic-like behavioral effects and cognitive enhancement by a potent and selective muscarinic M-sub-1 receptor agonist, AC-260584.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

MK-801 produces a deficit in sucrose preference that is reversed by clozapine, D-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: relevance to negative symptoms associated with schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Histamine H3 receptor antagonists/inverse agonists on cognitive and motor processes: relevance to Alzheimer's disease, ADHD, schizophrenia, and drug abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Learned helplessness in the rat: improvements in validity and reliability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Prenatal immune activation interacts with genetic Nurr1 deficiency in the development of attentional impairments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT₁A signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Long-lasting changes in hippocampal synaptic plasticity and cognition in an animal model of NMDA receptor dysfunction in psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Selectively bred Wistar–Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The validity of animal models of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Chronic mild stress-induced anhedonia: a realistic animal model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity rela

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The maternal immune activation (MIA) model of schizophrenia produces pre-pulse inhibition (PPI) deficits in both juvenile and adult rats but these effects are not associated with maternal weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Brain-specific Phgdh deletion reveals a pivotal role for L-serine biosynthesis in controlling the level of D-serine, an N-methyl-D-aspartate receptor co-agonist, in adult brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

An mGluR2/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Chronic blockade of CB(1) receptors reverses startle gating deficits and associated neurochemical alterations in rats reared in isolation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Abnormal stress responsivity in a rodent developmental disruption model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Olfactory bulbectomy in mice induces alterations in exploratory behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

Using the rat forced swim test to assess antidepressant-like activity in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1692-9

10.1007/S00441-013-1692-9

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

0 references

1 reference